Danimer Scientific Inc.

OTC: DNMR · Real-Time Price · USD
0.35
0.00 (0.00%)
At close: Mar 18, 2025, 3:58 PM

Danimer Scientific Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
46.68M 53.22M 58.75M
Cost of Revenue
73.64M 63.63M 57.87M
Gross Profit
-26.96M -10.41M 884K
Operating Income
-125.62M -187.43M -99.39M
Interest Income
n/a 1.72M 763K
Pretax Income
-155.15M -180.57M -73.34M
Net Income
-155.47M -179.76M -60.11M
Selling & General & Admin
68.98M 81.59M 80M
Research & Development
29.24M 31.94M 20.27M
Other Expenses
434K 723K -44K
Operating Expenses
98.66M 113.53M 100.27M
Interest Expense
n/a 112.25M 763K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
172.3M 177.16M 158.14M
Income Tax Expense
319K -810K -13.23M
Shares Outstanding (Basic)
102M 101.1M 93.08M
Shares Outstanding (Diluted)
102M 101.1M 93.08M
EPS (Basic)
-1.52 -1.78 -0.65
EPS (Diluted)
-1.52 -1.78 -0.65
EBITDA
-96.13M -103.49M -87.72M
EBIT
-125.19M -123.94M -99.39M
Depreciation & Amortization
29.06M 20.09M 11.67M